Stephen Rocamboli

Stephen Rocamboli

Director/Board Member presso ESPERION THERAPEUTICS, INC.

Patrimonio netto: 44 237 $ in data 31/03/2024

52 anni
Health Technology
Finance
Commercial Services

Profilo

Stephen Charles Rocamboli was the founder of Pear Tree Pharmaceuticals, Inc. (founded in 2008) where he held the title of President & Secretary from 2008 to 2018.
He is currently working as an Independent Director at Esperion Therapeutics, Inc., a Director at Cortice Biosciences, Inc., an Independent Director at TFF Pharmaceuticals, Inc. (since 2018), and a Director at Androvia Life Sciences.
In his former positions, he served as Chairman & Chief Executive Officer at Perla Therapeutics, Inc., Non-Executive Chairman & Secretary at VioQuest Pharmaceuticals, Inc. (from 2003 to 2009), Senior Managing Director & General Counsel at Paramount BioCapital, Inc. (from 1999 to 2007), and held various director roles at Cutanea Life Sciences, Inc., Foresight Biotherapeutics, Inc., Chitina Sciences, Inc., and Cordova Sciences, Inc. He also worked as Special Counsel at Wyrick Robbins Yates & Ponton LLP (from 2014 to 2015), Partner at Orion Biomedical Fund LP (from 1999 to 2007), and Deputy General Counsel at Paramount BioSciences LLC (from 1999 to 2004).
Additionally, he served as Secretary & Chief Business Officer at Candel Therapeutics, Inc. (from 2015 to 2020) and as General Partner at Integrin Partners LLC (from 2010 to 2015).
He was also a Partner at Beijing International Group LLC (from 2010 to 2012).
Mr. Rocamboli obtained an undergraduate degree from State University of New York at Albany and a graduate degree from Fordham University School of Law.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
15/06/2023 13 261 ( 0.01% ) 35 539 $ 31/03/2024
18/04/2024 1 440 ( 0.06% ) 8 698 $ 31/03/2024

Posizioni attive di Stephen Rocamboli

SocietàPosizioneInizio
TFF PHARMACEUTICALS, INC. Director/Board Member 01/12/2018
ESPERION THERAPEUTICS, INC. Director/Board Member 28/04/2022
Androvia Life Sciences Director/Board Member -
Director/Board Member -
Tutte le posizioni attive di Stephen Rocamboli

Precedenti posizioni note di Stephen Rocamboli

SocietàPosizioneFine
CANDEL THERAPEUTICS, INC. General Counsel 01/05/2020
Founder 01/05/2018
Corporate Officer/Principal 01/04/2015
Director/Board Member 01/01/2015
General Counsel 01/01/2015
Vedi nel dettaglio l'esperienza di Stephen Rocamboli

Formazione di Stephen Rocamboli

State University of New York at Albany Undergraduate Degree
Fordham University School of Law Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Stephen Rocamboli

Relazioni

75

Relazioni di 1° grado

20

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
VIOQUEST PHARMACEUTICALS, INC.

Health Technology

ESPERION THERAPEUTICS, INC.

Health Technology

CANDEL THERAPEUTICS, INC.

Health Technology

Aziende private15

Finance

Finance

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Orion Biomedical Fund LP

Finance

Health Technology

TFF Pharmaceuticals, Inc.

Commercial Services

Beijing International Group LLC

Androvia Life Sciences

Perla Therapeutics, Inc.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Stephen Rocamboli